HEPATIC INFECTION side effect
What is HEPATIC INFECTION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
HEPATIC INFECTION and Recently Reported Side Effects
HEPATIC INFECTION and 15 most Active Side Effect polls
HEPATIC INFECTION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with HEPATIC INFECTION
CELEBREX CYMBALTA FORTEO HALOPERIDOL NATALIZUMAB NEORAL PIOGLITAZONE REVLIMID ROGAINE TYSABRI VIDAZA XENICAL ZACTOS ZYPREXAZactos Side Effects Report #5678560-2
Consumer or non-health professional from MEXICO reported ZACTOS problem on Mar 10, 2008. Female patient, 55 years of age, was treated with ZACTOS. After drug was administered, patient experienced the following problems/side effects: hepatic infection, liver disorder, . ZACTOS dosage: unknown. During the same period patient was treated with HUMALOG. Patient recovered.
Pioglitazone Side Effects Report #5683801-1
PIOGLITAZONE problem was reported by a Consumer or non-health professional from MEXICO on Mar 17, 2008. Female patient was treated with PIOGLITAZONE. After drug was administered, patient experienced the following problems/side effects: hepatic infection, . PIOGLITAZONE dosage: unknown. During the same period patient was treated with HUMALOG. Patient recovered.
Cymbalta Side Effects Report #5615840-0
Physician from GERMANY reported CYMBALTA problem on Jan 25, 2008. Female patient, 55 years of age, was diagnosed with fibromyalgia and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic infection, liver disorder, . CYMBALTA dosage: unknown. Patient was hospitalized. Patient recovered.
Cymbalta Side Effects Report #5618896-4
CYMBALTA problem was reported by a Physician from GERMANY on Jan 25, 2008. Female patient, 55 years of age, was diagnosed with fibromyalgia and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: hepatic infection, liver disorder, . CYMBALTA dosage: unknown. Patient was hospitalized. Patient recovered.
Zyprexa Side Effects Report #5466781-3
Physician from SWITZERLAND reported ZYPREXA problem on Sept 14, 2007. Male patient was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: hepatic infection, myocardial infarction, oedema, overdose, . ZYPREXA dosage: UNK MG, UNK. Patient was hospitalized. Patient died.
Xenical Side Effects Report #5408445-8
XENICAL problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 27, 2007. Female patient, 67 years of age, was diagnosed with obesity and was treated with XENICAL. After drug was administered, patient experienced the following problems/side effects: hepatic infection, jaundice, . XENICAL dosage: unknown. Patient was hospitalized. Patient recovered.
Rogaine Side Effects Report #5387541-8
Physician from UNITED KINGDOM reported ROGAINE problem on July 02, 2007. Female patient was diagnosed with alopecia and was treated with ROGAINE. After drug was administered, patient experienced the following problems/side effects: hepatic infection, hepatocellular damage, . ROGAINE dosage: unknown. Patient recovered.
Rogaine Side Effects Report #5387541-8
ROGAINE problem was reported by a Physician from UNITED KINGDOM on July 02, 2007. Female patient was diagnosed with alopecia and was treated with ROGAINE. After drug was administered, patient experienced the following problems/side effects: hepatic infection, hepatocellular damage, . ROGAINE dosage: unknown. Patient recovered.
Rogaine Side Effects Report #5348530-2
Consumer or non-health professional from UNITED KINGDOM reported ROGAINE problem on May 23, 2007. Female patient was diagnosed with alopecia and was treated with ROGAINE. After drug was administered, patient experienced the following problems/side effects: hepatic infection, hepatocellular damage, . ROGAINE dosage: unknown. Patient recovered.
Rogaine Side Effects Report #5314226-6
ROGAINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 13, 2007. Female patient was diagnosed with alopecia and was treated with ROGAINE. After drug was administered, patient experienced the following problems/side effects: hepatic infection, hepatocellular damage, . ROGAINE dosage: unknown. Patient recovered.
Neoral Side Effects Report #5675708-0
Consumer or non-health professional from FRANCE reported NEORAL problem on Mar 14, 2008. Male patient, 66 years of age, was diagnosed with liver and small intestine transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, hepatic infection, liver abscess, neutropenia, pyrexia, . NEORAL dosage: 250 MG, BID. During the same period patient was treated with CELLCEPT, CORTANCYL, ROVALCYTE, ESOMEPRAZOLE MAGNESIUM, TEMESTA, ASPEGIC. Patient was hospitalized. Patient recovered.
Haloperidol Side Effects Report #5472409-9
HALOPERIDOL problem was reported by a Physician from SWITZERLAND on Sept 21, 2007. Male patient, 23 years of age, was diagnosed with acute psychosis and was treated with HALOPERIDOL. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, hepatic infection, oedema, overdose, pyrexia, rash, suicidal behaviour, . HALOPERIDOL dosage: unknown. During the same period patient was treated with ZYPREXA. Patient was hospitalized. Patient died on 01/09/2007.
Zyprexa Side Effects Report #5480228-2
Physician from SWITZERLAND reported ZYPREXA problem on Oct 01, 2007. Male patient, 23 years of age, was diagnosed with acute psychosis and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, hepatic infection, oedema, overdose, pyrexia, rash, suicidal behaviour, . ZYPREXA dosage: unknown. During the same period patient was treated with HALOPERIDOL. Patient was hospitalized. Patient died on 01/09/2007.
Revlimid Side Effects Report #5761839-3
REVLIMID problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2008. Male patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: axillary pain, hepatic infection, pulmonary thrombosis, . REVLIMID dosage: unknown. Patient was hospitalized. Patient recovered.
Neoral Side Effects Report #5694426-6
Consumer or non-health professional from FRANCE reported NEORAL problem on Mar 31, 2008. Male patient, 66 years of age, was diagnosed with liver and small intestine transplant and was treated with NEORAL. After drug was administered, patient experienced the following problems/side effects: agranulocytosis, hepatic infection, liver abscess, neutropenia, pyrexia, . NEORAL dosage: 250 MG, BID. During the same period patient was treated with CELLCEPT, CORTANCYL, ROVALCYTE, ESOMEPRAZOLE, TEMESTA, ASPEGIC. Patient was hospitalized. Patient recovered.
Forteo Side Effects Report #5361977-3
FORTEO problem was reported by a Consumer or non-health professional from CANADA on June 05, 2007. Female patient, 62 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: abdominal pain, hepatic infection, pancreatitis, . FORTEO dosage: unknown. During the same period patient was treated with HYDROMORPHONE, DURAGESIC, PAXIL, DOMPERIDONE, ATIVAN, IMOVANE. Patient was hospitalized. Patient recovered.
Celebrex Side Effects Report #5656044-5
Consumer or non-health professional from UNITED STATES reported CELEBREX problem on Feb 26, 2008. Female patient, weighting 164.9 lb, was diagnosed with osteoporosis and was treated with CELEBREX. After drug was administered, patient experienced the following problems/side effects: cholecystitis infective, diabetes mellitus, hepatic infection, lip blister, neuropathy peripheral, pernicious anaemia, skin discolouration, swelling face, . CELEBREX dosage: unknown. During the same period patient was treated with VITAMIN B. Patient recovered.
Tysabri Side Effects Report #5626850-1
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 30, 2008. Female patient, 61 years of age, weighting 199.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: bacteraemia, hallucination, hepatic infection, migraine, urinary tract infection, white blood cell count increased, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5445758-8
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Aug 21, 2007. Female patient, 61 years of age, weighting 199.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: bacteraemia, hallucination, hepatic infection, kidney infection, migraine, urinary tract infection, white blood cell count increased, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5430400-2
NATALIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2007. Female patient, 61 years of age, weighting 199.0 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: blood disorder, hallucination, hepatic infection, migraine, urinary tract infection, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5293978-8
Physician from UNITED STATES reported VIDAZA problem on Mar 23, 2007. Female patient, 47 years of age, weighting 135.4 lb, was diagnosed with myelodysplastic syndrome, decreased appetite and was treated with VIDAZA. After drug was administered, patient experienced the following problems/side effects: decreased appetite, fungal infection, hepatic infection, lung neoplasm, pulmonary embolism, . VIDAZA dosage: 40 MG/M2 (DAYS 1 TO 10, EVERY 28 DAYS), SUBCUTANEOUS. During the same period patient was treated with MEGACE, ATIVAN, VFEND, CASPOFUNGIN. Patient recovered.